FDA approves Eisai and Merck’s Lenvima for first-line treatment of liver cancer

In a significant development for cancer treatment, Eisai and Merck have announced that the U.S. Food and Drug Administration (FDA) has approved Lenvima (lenvatinib) for ... Read More